Meridian Bioscience to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call on November 13, 2020

Rhea-AI Summary

Meridian Bioscience, Inc. (NASDAQ: VIVO) will announce its fourth quarter and full year 2020 financial results on November 13, 2020. CEO Jack Kenny and CFO Bryan Baldasare will lead a conference call at 10:00 a.m. ET to discuss the financial performance and answer questions. Participants can join the call via phone, with replay options available for 14 days after the event. Meridian is a comprehensive life science firm providing diagnostic and life science solutions globally, serving diverse sectors including healthcare and research.

CINCINNATI, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report fourth quarter and full year 2020 financial results Friday, November 13, 2020.

Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and Chief Financial Officer, will host a conference call beginning at 10:00 a.m. Eastern Time to discuss the results and answer questions.

To participate in the live call by telephone from the U.S., dial (866) 443-5802, or from outside the U.S., dial (513) 360-6924, and enter the audience pass code 3958286.

A replay will be available for 14 days beginning at 1:00 p.m. Eastern Time on November 13, 2020 by dialing (855) 859-2056 or (404) 537-3406 and entering pass code 3958286.

About Meridian Bioscience, Inc.
Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. We build relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.

Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is www.meridianbioscience.com.

Contact:
Charlie Wood
Vice President – Investor Relations
Meridian Bioscience, Inc.
Phone: +1 513.271.3700
Email: mbi@meridianbioscience.com

FAQ

When will Meridian Bioscience report its fourth quarter and full year 2020 financial results?

Meridian Bioscience will report its financial results on November 13, 2020.

Who will host the conference call for Meridian's financial results?

The conference call will be hosted by CEO Jack Kenny and CFO Bryan Baldasare.

What time is the conference call for Meridian Bioscience's financial results?

The conference call is scheduled for 10:00 a.m. Eastern Time.

How can I access the replay of Meridian Bioscience's conference call?

The replay can be accessed by calling (855) 859-2056 or (404) 537-3406 with pass code 3958286, available for 14 days after the call.

What is the stock symbol for Meridian Bioscience?

The stock symbol for Meridian Bioscience is VIVO.